Mirum Pharmaceuticals
MIRM
MIRM
146 hedge funds and large institutions have $956M invested in Mirum Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
15% more capital invested
Capital invested by funds: $833M → $956M (+$123M)
5.77% more ownership
Funds ownership: 91.37% → 97.14% (+5.8%)
64% less call options, than puts
Call options by funds: $486K | Put options by funds: $1.33M
Holders
146
Holding in Top 10
9
Calls
$486K
Puts
$1.33M
Top Buyers
| 1 | +$37.2M | |
| 2 | +$24.3M | |
| 3 | +$14.1M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$13.3M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$8.97M |
Top Sellers
| 1 | -$53.2M | |
| 2 | -$48.8M | |
| 3 | -$5.84M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5.21M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.72M |